The Texas Medical Board and Texas State Board of Pharmacy released a joint statement, September 3, reaffirming that the agencies do not endorse or prohibit any particular COVID-19 treatment.
The statement specifically notes that drugs may be prescribed off-label.
That presumably includes treatments like Ivermectin and Hydroxychloroqine that have reported success against COVID, but that have been subject to government and media information blackout.
National Institutes of Health’s own Medical Library website contains an article that reports Ivermectin works against COVID (LINK).
Florida’s Board of Medicine did not respond to a Panhandle Politico inquiry for comment.
The full Texas statement reads:
“The Texas Medical Board (TMB) and Texas State Board of Pharmacy (TSBP) do not endorse or prohibit any particular prescribed drugs or treatment for COVID-19 that meet the standard of care. Drugs are permitted to be prescribed off-label. It is the professional judgement of each physician to write their prescriptions while meeting all applicable federal and state statutes and rules. Similarly, each pharmacist must use their professional judgement in dispensing valid prescriptions while meeting all applicable federal and state statutes and rules.”PDF Embedder requires a url attribute